已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis

医学 恶性胸腔积液 胸膜成形术 内科学 荟萃分析 胸腔积液 中医药 随机对照试验 肿瘤科 病理 替代医学
作者
Cheng-Qiong Wang,Jiao Xu,Hong Jiang,Xiao-Tian Zheng,Yan Zhang,Xiao-Rong Huang,Fei She,Teng-Yang Fan,Lin Zhan,Jihong Feng,Qihai Gong,Xue Xiao,Xiaofan Chen,Zheng Xiao
出处
期刊:Phytomedicine [Elsevier]
卷期号:115: 154847-154847 被引量:5
标识
DOI:10.1016/j.phymed.2023.154847
摘要

Aidi injection (Aidi), a traditional Chinese medicine injection, is often practiced to control malignant pleural effusion (MPE). We performed a registered systematic review and meta-analysis (PROSPERO: CRD42022337611) to clarify the clinical role of Aidi in MPE, reveal optimal combinations of Aidi and chemical agents, their indications, therapeutic route and usage, and demonstrate their clinical effectiveness and safety. All randomized controlled trials (RCTs) about Aidi in controlling MPE were collected from Chinese and English databases (up to October 2022). We clustered them into multiple homogenous regimens, evaluated the risk-of-bias at outcome level using a RoB 2, extracted and pooled the data using meta-analysis or descriptive analysis, and finally summarized their evidence quality. All 56 studies were clustered into intrapleural administration with Aidi alone or plus chemical agents, and intravenous administration with Aidi for MPE. Intrapleural administration with Aidi alone displayed similar clinical responses on Cisplatin (DDP) alone. Only administration with Aidi plus DDP significantly improved complete response and quality of life, and displayed a low pleurodesis failure, disease progression, hematotoxicity, gastrointestinal and hepatorenal toxicity. For patients with moderate to massive effusion, Karnofsky Performance Status score ≥ 50 or anticipated survival time ≥3 months, Aidi (50 ml to 80 ml each time, one time each week and three to eight times) plus DDP (20 to 30 mg, 40 to 50 mg, or 60 to 80 mg each time) significantly improved clinical responses. Most results had moderate to low quality. Current evidences indicate that Aidi, a pleurodesis agent, plays an interesting clinical role in controlling MPE. Aidi plus DDP perfusion is a most commonly used regimen, which shows a significant improvement in clinical responses. These findings also provide an indication and possible optimal usage for rational drug use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
3秒前
吉如天完成签到,获得积分10
3秒前
4秒前
轴承完成签到 ,获得积分10
6秒前
ding应助飘逸的鞋子采纳,获得10
6秒前
8秒前
zl13332完成签到 ,获得积分10
9秒前
肥肠的枣糕啊完成签到,获得积分10
12秒前
小小发布了新的文献求助30
12秒前
13秒前
14秒前
15秒前
fedehe完成签到 ,获得积分10
15秒前
YifanWang应助潇潇雨歇采纳,获得10
17秒前
ZhouLin发布了新的文献求助10
17秒前
双眼皮跳蚤完成签到,获得积分0
20秒前
善学以致用应助Augustines采纳,获得10
27秒前
Mark完成签到 ,获得积分10
27秒前
ZhouLin完成签到,获得积分10
27秒前
hvu完成签到,获得积分10
28秒前
朴素海亦完成签到 ,获得积分10
32秒前
fsznc完成签到 ,获得积分0
33秒前
33秒前
为什么这篇文献又没有完成签到,获得积分10
36秒前
Lucas应助寰2023采纳,获得10
36秒前
william完成签到 ,获得积分10
38秒前
疯狂的娃哈哈完成签到 ,获得积分10
40秒前
儒雅完成签到 ,获得积分10
40秒前
土豪的摩托完成签到 ,获得积分10
42秒前
43秒前
AZN完成签到,获得积分10
43秒前
YifanWang应助潇潇雨歇采纳,获得10
44秒前
科研通AI6应助聪明怜阳采纳,获得10
45秒前
45秒前
辣椒完成签到 ,获得积分10
48秒前
49秒前
刘雨森完成签到 ,获得积分10
51秒前
54秒前
56秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
List of 1,091 Public Pension Profiles by Region 1621
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] | NHBS Field Guides & Natural History 1500
The Victim–Offender Overlap During the Global Pandemic: A Comparative Study Across Western and Non-Western Countries 1000
King Tyrant 720
T/CIET 1631—2025《构网型柔性直流输电技术应用指南》 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5590251
求助须知:如何正确求助?哪些是违规求助? 4674657
关于积分的说明 14794952
捐赠科研通 4630846
什么是DOI,文献DOI怎么找? 2532648
邀请新用户注册赠送积分活动 1501221
关于科研通互助平台的介绍 1468576